The estimated Net Worth of Pierre Legault is at least $901 Thousand dollars as of 12 January 2023. Mr. Legault owns over 39,000 units of Syndax Pharmaceuticals Inc stock worth over $677,840 and over the last 18 years he sold SNDX stock worth over $0. In addition, he makes $223,246 as Independent Director at Syndax Pharmaceuticals Inc.
Pierre has made over 9 trades of the Syndax Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 39,000 units of SNDX stock worth $430,950 on 12 January 2023.
The largest trade he's ever made was exercising 150,000 units of Syndax Pharmaceuticals Inc stock on 20 December 2021 worth over $1,269,000. On average, Pierre trades about 7,744 units every 17 days since 2007. As of 12 January 2023 he still owns at least 37,000 units of Syndax Pharmaceuticals Inc stock.
You can see the complete history of Mr. Legault stock trades at the bottom of the page.
Pierre Legault CPA serves as Independent Director of the Company. Mr. Legault also serves on the board of Artios Pharma (Chairman), Bicycle Therapeutics (Chairman), Poxel Pharmaceuticals (Chairman), Clementia Pharmaceuticals and Urovant Sciences. Previously, he served on the board of Armo BioSciences, Iroko Pharmaceuticals, Tobira Therapeutics, NPS Pharmaceuticals, Forest Laboratories, Cyclacel Pharmaceuticals, Eckerd Pharmacy, Regado Biosciences, NephroGenex and several others. Mr. Legault served as Chairman of NephroGenex, a biopharmaceutical company, from 2012 through 2013, and as Chief Executive Officer from 2014 through 2016, as Chief Executive Officer of Prosidion from 2010 through 2012, and Executive Vice President, Chief Financial Officer, and Treasurer of OSI Pharmaceuticals from 2009 through 2010. His prior senior executive experience also includes serving as President of Eckerd Pharmacy and as Executive Vice President and Chief Administrative Officer of Rite Aid Corporation. He also held several senior positions with Sanofi-Aventis and predecessor companies, including President of Worldwide Dermatology Operations. Mr. Legault studied at McGill University, HEC Montreal and Harvard Business School. He holds an M.B.A., BAA, CA, CPA and Six Sigma Green Belt diplomas.
As the Independent Director of Syndax Pharmaceuticals Inc, the total compensation of Pierre Legault at Syndax Pharmaceuticals Inc is $223,246. There are 6 executives at Syndax Pharmaceuticals Inc getting paid more, with Michael Metzger having the highest compensation of $2,696,890.
Pierre Legault is 59, he's been the Independent Director of Syndax Pharmaceuticals Inc since 2017. There are 6 older and 11 younger executives at Syndax Pharmaceuticals Inc. The oldest executive at Syndax Pharmaceuticals Inc is Dr. Michael L. Meyers M.D., Ph.D., 70, who is the Chief Medical Officer & Sr. VP.
Pierre's mailing address filed with the SEC is C/O SYNDAX PHARMACEUTICALS, INC., 35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM, MA, 02451.
Over the last 9 years, insiders at Syndax Pharmaceuticals Inc have traded over $1,950,406 worth of Syndax Pharmaceuticals Inc stock and bought 210,921 units worth $2,347,816 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Luke Evnin, and Briggs Morrison. On average, Syndax Pharmaceuticals Inc executives and independent directors trade stock every 50 days with the average trade being worth of $745,679. The most recent stock trade was executed by Keith A. Goldan on 14 June 2024, trading 1,250 units of SNDX stock currently worth $25,038.
syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451.
Syndax Pharmaceuticals Inc executives and other stock owners filed with the SEC include: